PharmaLifeScience News

...

Data silos hold back Irish clinical research

Data silos hinder Irish clinical research. Fragmented IT infrastructure limits data access and collaboration, slowing progress. Learn how experts like Professor Frank Sullivan propose overcoming these challenges.
READ MORE
...

Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing

The Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P. Morgan Private Capital closed its first fund and the FDA gave new COVID shot advice.
READ MORE
...

Innovative 3D cell culturing method offers new insights into cancer cell mechanics

Developing chemotherapy drugs against breast cancer is costly, slow, and often inefficient, with more than 95% of screened drug candidates failing in patient trials.
READ MORE